New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis

[1]  Thomas D. Schmittgen,et al.  MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. , 2006, The Journal of Biological Chemistry.

[2]  J. Qian,et al.  miR-29 is a major regulator of genes associated with pulmonary fibrosis. , 2011, American journal of respiratory cell and molecular biology.

[3]  S. Sahn,et al.  Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials , 2011, The Lancet.

[4]  D. Lynch,et al.  BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[5]  H. Weiner,et al.  MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α–PU.1 pathway , 2011, Nature Medicine.

[6]  A. Desmoulière,et al.  The Myofibroblast: one function, multiple origins , 2010 .

[7]  E. Olson,et al.  Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. , 2010, Cancer cell.

[8]  H. Collard,et al.  A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. , 2010, The New England journal of medicine.

[9]  T. Kawabe,et al.  Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. , 2010, American journal of respiratory cell and molecular biology.

[10]  Chunxiang Zhang,et al.  Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. , 2010, Cardiovascular research.

[11]  Oliver Eickelberg,et al.  Inhibition and role of let-7d in idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[12]  S. Nathan,et al.  Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. , 2010, Respiratory medicine.

[13]  E. White,et al.  Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts. , 2010, Experimental cell research.

[14]  J. Hagood,et al.  Thy-1-Integrin αvβ5 Interactions Inhibit Lung Fibroblast Contraction-induced Latent Transforming Growth Factor-β1 Activation and Myofibroblast Differentiation* , 2010, The Journal of Biological Chemistry.

[15]  N. Kaminski,et al.  miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis , 2010, The Journal of experimental medicine.

[16]  D. Fairclough,et al.  Pirfenidone in idiopathic pulmonary fibrosis , 2010, European Respiratory Journal.

[17]  D. Schroeder,et al.  Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results. , 2010, American journal of respiratory and critical care medicine.

[18]  M. Selman,et al.  Risk factors for idiopathic pulmonary fibrosis in a Mexican population. A case-control study. , 2010, Respiratory medicine.

[19]  E. Pålsson-McDermott,et al.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21 , 2010, Nature Immunology.

[20]  S. Kauppinen,et al.  Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.

[21]  Margaret A. Strong,et al.  Short telomeres are sufficient to cause the degenerative defects associated with aging. , 2009, American journal of human genetics.

[22]  G. Raghu,et al.  Pirfenidone in idiopathic pulmonary fibrosis , 2009, European Respiratory Journal.

[23]  E. Neilson,et al.  Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. , 2009, American journal of respiratory and critical care medicine.

[24]  H. Collard,et al.  Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. , 2009, Chest.

[25]  P. Barbry,et al.  Identification of Keratinocyte Growth Factor as a Target of microRNA-155 in Lung Fibroblasts: Implication in Epithelial-Mesenchymal Interactions , 2009, PloS one.

[26]  K. Wittkowski,et al.  In Vitro and In Vivo Evidence that Thrombospondin-1 (TSP-1) Contributes to Stirring- and Shear-Dependent Activation of Platelet-Derived TGF-β1 , 2009, PloS one.

[27]  G. Wolf,et al.  TGF-beta and fibrosis in different organs - molecular pathway imprints. , 2009, Biochimica et biophysica acta.

[28]  Ning Wang,et al.  Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. , 2009, Cardiovascular research.

[29]  W. MacNee,et al.  Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). , 2009, Biochemical Society transactions.

[30]  Yaou Zhang,et al.  MicroRNA MiR-17 retards tissue growth and represses fibronectin expression , 2009, Nature Cell Biology.

[31]  P. Tam.  Faculty Opinions recommendation of miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. , 2009 .

[32]  S. Sahn,et al.  Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial , 2009, The Lancet.

[33]  Chunxiang Zhang,et al.  MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation , 2009, Circulation research.

[34]  E. Abrahams,et al.  The Case for Personalized Medicine , 2009, Journal of diabetes science and technology.

[35]  Dan Xu,et al.  Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats , 2009, Respiratory research.

[36]  F. Martinez,et al.  NADPH Oxidase-4 Mediates Myofibroblast Activation and Fibrogenic Responses to Lung Injury , 2009, Nature Medicine.

[37]  R. Hubbard,et al.  Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis. , 2009, Respiratory medicine.

[38]  K. Brown,et al.  Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. , 2009, Chest.

[39]  M. Olschewski,et al.  Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[40]  M. Selman,et al.  MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility , 2009, Human Genetics.

[41]  G. Nuovo,et al.  MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. , 2009, Cardiovascular research.

[42]  J. Rossi,et al.  TGF-β activates Akt kinase via a microRNA-dependent amplifying circuit targeting PTEN , 2009, Nature Cell Biology.

[43]  E. Savarino,et al.  Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. , 2009, American journal of respiratory and critical care medicine.

[44]  R. Duisters,et al.  MIRNA-133 AND MIRNA-30 REGULATE CONNECTIVE TISSUE GROWTH FACTOR: IMPLICATIONS FOR A ROLE OF MIRNAS IN MYOCARDIAL MATRIX REMODELING , 2013 .

[45]  Michael P. Sheetz,et al.  The mechanical integrin cycle , 2009, Journal of Cell Science.

[46]  D. Rifkin,et al.  Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin. , 2009, The American journal of pathology.

[47]  M. Raza.  BUILD-1: A Randomized Placebo-Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis , 2009 .

[48]  D. Brenner.  Molecular pathogenesis of liver fibrosis. , 2009, Transactions of the American Clinical and Climatological Association.

[49]  W. Rottbauer,et al.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts , 2008, Nature.

[50]  R. Hubbard,et al.  The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. , 2008, American journal of respiratory and critical care medicine.

[51]  G. Raghu,et al.  Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. , 2008, American journal of respiratory and critical care medicine.

[52]  D. Rifkin,et al.  In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1. , 2008, Blood.

[53]  C. Ruppert,et al.  Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. , 2008, American journal of respiratory and critical care medicine.

[54]  M. Selman,et al.  MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis , 2008, Human Genetics.

[55]  Hongju Wu,et al.  Focal Adhesion Kinase (FAK)-related Non-kinase Inhibits Myofibroblast Differentiation through Differential MAPK Activation in a FAK-dependent Manner* , 2008, Journal of Biological Chemistry.

[56]  G. Fortunato,et al.  Prevalência de refluxo gastroesofágico em pacientes com doença pulmonar avançada candidatos a transplante pulmonar , 2008 .

[57]  M. Oka,et al.  Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension , 2008, British journal of pharmacology.

[58]  L. Fink,et al.  Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[59]  G. Raghu,et al.  Telomere shortening in familial and sporadic pulmonary fibrosis. , 2008, American journal of respiratory and critical care medicine.

[60]  V. Thannickal,et al.  Idiopathic pulmonary fibrosis: a disorder of lung regeneration? , 2008, American journal of respiratory and critical care medicine.

[61]  S. Garneau‐Tsodikova,et al.  Protein kinase inhibitors in the treatment of pulmonary fibrosis. , 2008, Current medicinal chemistry.

[62]  Jeffrey E. Thatcher,et al.  Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis , 2008, Proceedings of the National Academy of Sciences.

[63]  P. Lansdorp,et al.  Short telomeres are a risk factor for idiopathic pulmonary fibrosis , 2008, Proceedings of the National Academy of Sciences.

[64]  K. Preissner,et al.  Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types. , 2008, American journal of respiratory cell and molecular biology.

[65]  Peter F. Crossno,et al.  Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[66]  M. Korpal,et al.  The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2* , 2008, Journal of Biological Chemistry.

[67]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[68]  J. Zwerina,et al.  Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis. , 2008, Arthritis and rheumatism.

[69]  A. Halayko,et al.  Rho kinase inhibitors: a novel therapeutical intervention in asthma? , 2008, European journal of pharmacology.

[70]  Sun-Mi Park,et al.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.

[71]  J. Wood,et al.  Occupational Risks for Idiopathic Pulmonary Fibrosis Mortality in the United States , 2008, International journal of occupational and environmental health.

[72]  Naftali Kaminski,et al.  MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis , 2008, PLoS medicine.

[73]  B. Moore,et al.  Exacerbation of Established Pulmonary Fibrosis in a Murine Model by Gammaherpesvirus at a Glance Commentary , 2022 .

[74]  N. Kaminski,et al.  A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. , 2008, The American journal of pathology.

[75]  K. Kostikas,et al.  Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. , 2008, Pulmonary pharmacology & therapeutics.

[76]  J. Parsons,et al.  Focal Adhesion Kinase: Targeting Adhesion Signaling Pathways for Therapeutic Intervention , 2008, Clinical Cancer Research.

[77]  A. Nicholson,et al.  Idiopathic pulmonary fibrosis: outcome in relation to smoking status. , 2008, American journal of respiratory and critical care medicine.

[78]  C. F. Andrade,et al.  Prevalence of gastroesophageal reflux in lung transplant candidates with advanced lung disease. , 2008, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[79]  B. Hinz,et al.  Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix , 2007, The Journal of cell biology.

[80]  K. Torén,et al.  Occupational exposure and severe pulmonary fibrosis. , 2007, Respiratory medicine.

[81]  M. Blasco,et al.  Telomere length, stem cells and aging. , 2007, Nature chemical biology.

[82]  J. Campisi,et al.  Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.

[83]  B. Willis,et al.  TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease , 2007 .

[84]  S. Ichinose,et al.  Inhalation of inorganic particles as a risk factor for idiopathic pulmonary fibrosis--elemental microanalysis of pulmonary lymph nodes obtained at autopsy cases. , 2007, Pathology, research and practice.

[85]  J. Lambeth.  Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. , 2007, Free radical biology & medicine.

[86]  P. Sime,et al.  TGF-β, Smad3 and the process of progressive fibrosis , 2007 .

[87]  J. Liao,et al.  Rho Kinase (ROCK) Inhibitors , 2007, Journal of cardiovascular pharmacology.

[88]  Chao Xing,et al.  Adult-onset pulmonary fibrosis caused by mutations in telomerase , 2007, Proceedings of the National Academy of Sciences.

[89]  David S. Rogers,et al.  Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. , 2007, Cellular signalling.

[90]  J. Golden,et al.  Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. , 2007, The Journal of thoracic and cardiovascular surgery.

[91]  John J Rossi,et al.  MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors , 2007, Proceedings of the National Academy of Sciences.

[92]  B. Willis,et al.  TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[93]  P. Sime,et al.  TGF-beta, Smad3 and the process of progressive fibrosis. , 2007, Biochemical Society transactions.

[94]  A. Dasari,et al.  Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. , 2006, Cancer research.

[95]  J. Hagood,et al.  Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. , 2006, Biochimica et biophysica acta.

[96]  G. Oster,et al.  Incidence and prevalence of idiopathic pulmonary fibrosis. , 2006, American journal of respiratory and critical care medicine.

[97]  D. Sheppard,et al.  Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix , 2006, Proceedings of the National Academy of Sciences.

[98]  V. Poletti,et al.  Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis , 2006, Respiratory research.

[99]  R. Chambers,et al.  Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. , 2006, The Journal of clinical investigation.

[100]  D. Coultas,et al.  Is idiopathic pulmonary fibrosis an environmental disease? , 2006, Proceedings of the American Thoracic Society.

[101]  F. Chu,et al.  Alteration of fibroblast architecture and loss of Basal lamina apertures in human emphysematous lung. , 2006, American journal of respiratory and critical care medicine.

[102]  G. Raghu,et al.  Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. , 2006, Chest.

[103]  S. Nathan,et al.  Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. , 2006, Chest.

[104]  K. Flanders,et al.  Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. , 2006, Cytokine & growth factor reviews.

[105]  G. Raghu,et al.  High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis , 2006, European Respiratory Journal.

[106]  T. Nishikimi,et al.  Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis. , 2006, Journal of pharmacological sciences.

[107]  Johny Verschakelen,et al.  High-dose acetylcysteine in idiopathic pulmonary fibrosis. , 2005, The New England journal of medicine.

[108]  H Page McAdams,et al.  Clinical and pathologic features of familial interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.

[109]  M. Rojas,et al.  Lung infection with γ-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice , 2005 .

[110]  John Calvin Reed,et al.  Endoplasmic reticulum stress: cell life and death decisions. , 2005, The Journal of clinical investigation.

[111]  G. Darling,et al.  Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. , 2005, The Annals of thoracic surgery.

[112]  Katsutoshi Nakayama,et al.  Anticoagulant therapy for idiopathic pulmonary fibrosis. , 2005, Chest.

[113]  R. Irwin,et al.  Chronic cough in adults with interstitial lung disease , 2005, Current opinion in pulmonary medicine.

[114]  Dean Sheppard,et al.  Integrin-mediated activation of latent transforming growth factor β , 2005, Cancer and Metastasis Reviews.

[115]  T. Oury,et al.  Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. , 2005, American journal of respiratory and critical care medicine.

[116]  C. B. Alexander,et al.  Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. , 2005, The American journal of pathology.

[117]  F. Martinez,et al.  The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis , 2005, Annals of Internal Medicine.

[118]  V. Poletti,et al.  HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis. , 2005, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[119]  S. Kudoh,et al.  Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2005, American journal of respiratory and critical care medicine.

[120]  J. Horowitz,et al.  Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[121]  A. Nicholson,et al.  Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. , 2005, The American journal of pathology.

[122]  N. Siafakas,et al.  Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. , 2005, European journal of internal medicine.

[123]  S. Kudoh,et al.  Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan. , 2005, The Annals of occupational hygiene.

[124]  P. Pellikka,et al.  Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. , 2004, Chest.

[125]  M. Rojas,et al.  Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[126]  H. von Melchner,et al.  Disruption of LTBP-4 function reduces TGF-β activation and enhances BMP-4 signaling in the lung , 2004, The Journal of cell biology.

[127]  H. Shimokawa,et al.  Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats , 2004, Journal of hypertension.

[128]  J. Hagood,et al.  Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. , 2004, The American journal of pathology.

[129]  D. Bartel,et al.  Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs , 2004, Nature Reviews Genetics.

[130]  G. Raghu,et al.  A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. , 2004, The New England journal of medicine.

[131]  J. Keski‐Oja,et al.  Latent TGF-β Binding Proteins: Extracellular Matrix Association and Roles in TGF-β Activation , 2004 .

[132]  J. Keski‐Oja,et al.  Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. , 2004, Critical reviews in clinical laboratory sciences.

[133]  J. Mullol,et al.  Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[134]  J. Kyriakis,et al.  Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-beta-induced nuclear accumulation. , 2003, American journal of physiology. Cell physiology.

[135]  B. Hinz,et al.  Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. , 2003, Molecular biology of the cell.

[136]  J. Oates,et al.  Herpesvirus DNA Is Consistently Detected in Lungs of Patients with Idiopathic Pulmonary Fibrosis , 2003, Journal of Clinical Microbiology.

[137]  M. Sawabe,et al.  A clinical study of idiopathic pulmonary fibrosis based on autopsy studies in elderly patients. , 2003, Internal medicine.

[138]  V. Poletti,et al.  Aberrant Wnt/ (cid:1) -Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis , 2003 .

[139]  J. Parsons,et al.  Focal adhesion kinase: the first ten years , 2003, Journal of Cell Science.

[140]  R. Day,et al.  Myofibroblast Differentiation by Transforming Growth Factor-β1 Is Dependent on Cell Adhesion and Integrin Signaling via Focal Adhesion Kinase* , 2003, The Journal of Biological Chemistry.

[141]  C. Smith,et al.  Unique structural features that influence neutrophil emigration into the lung. , 2003, Physiological reviews.

[142]  H. Uchiyama,et al.  Lack of evidence for a role of Epstein-Barr virus in the increase of lung cancer in idiopathic pulmonary fibrosis. , 2003, Respiratory medicine.

[143]  K. Kuwano,et al.  Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias , 2003, European Respiratory Journal.

[144]  D. Rifkin,et al.  Latent Transforming Growth Factor β-binding Protein 1 Interacts with Fibrillin and Is a Microfibril-associated Protein* , 2003, The Journal of Biological Chemistry.

[145]  Justin P. Annes,et al.  Making sense of latent TGFβ activation , 2003, Journal of Cell Science.

[146]  榎本 達治.  Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis , 2003 .

[147]  古川 富紀子.  p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts , 2003 .

[148]  V. Poletti,et al.  Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. , 2003, The American journal of pathology.

[149]  D. Rifkin,et al.  Making sense of latent TGFbeta activation. , 2003, Journal of cell science.

[150]  J. Mullol,et al.  Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[151]  J. Stewart,et al.  A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.

[152]  B. Hinz,et al.  The NH2-terminal peptide of α–smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo , 2002, The Journal of cell biology.

[153]  M. Hori,et al.  Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. , 2002, Kidney international.

[154]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[155]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[156]  P. McKeown-Longo,et al.  TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion. , 2001, Journal of cell science.

[157]  J. Tooze,et al.  Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. , 2001, American journal of respiratory and critical care medicine.

[158]  T. Nakamura,et al.  Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells. , 2001, Journal of hepatology.

[159]  J. Stewart,et al.  Epstein-Barr virus and wild p53 in idiopathic pulmonary fibrosis. , 2001, Respiratory medicine.

[160]  J. Keski‐Oja,et al.  Novel non-TGF-β-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-β deposition , 2001 .

[161]  R. Budhiraja,et al.  Oxidative Protein Cross-linking Reactions Involvingl-Tyrosine in Transforming Growth Factor-β1-stimulated Fibroblasts* , 2001, The Journal of Biological Chemistry.

[162]  A. Pardo,et al.  Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy , 2001, Annals of Internal Medicine.

[163]  J. Keski‐Oja,et al.  Novel non-TGF-beta-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-beta deposition. , 2001, Journal of Cell Science.

[164]  J. Keski‐Oja,et al.  Latent TGF-beta binding protein LTBP-1 contains three potential extracellular matrix interacting domains. , 2001, Journal of cell science.

[165]  E. Medrano,et al.  Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes , 2000, Experimental Gerontology.

[166]  J. Samet,et al.  Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. , 2000, American journal of epidemiology.

[167]  K. M. Mulder,et al.  Role of Ras and Mapks in TGFβ signaling , 2000 .

[168]  Arnold Simanowitz,et al.  international consensus statement , 2000 .

[169]  K. M. Mulder.  Role of Ras and Mapks in TGFbeta signaling. , 2000, Cytokine & growth factor reviews.

[170]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[171]  Fumio Matsumura,et al.  Phosphorylation of Myosin-Binding Subunit (Mbs) of Myosin Phosphatase by Rho-Kinase in Vivo , 1999, The Journal of cell biology.

[172]  S. Mai,et al.  Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. , 1999, The American journal of pathology.

[173]  A. Woodcock,et al.  The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. , 1999, American journal of respiratory and critical care medicine.

[174]  N. Kaminski,et al.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.

[175]  G. Raghu,et al.  Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[176]  P. Montuschi,et al.  8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. , 1998, American journal of respiratory and critical care medicine.

[177]  Y. Ouchi,et al.  Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis. , 1998, Journal of clinical pathology.

[178]  A. Degraff,et al.  Case-control study of idiopathic pulmonary fibrosis and environmental exposures. , 1998, Journal of occupational and environmental medicine.

[179]  K. Csaky,et al.  Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. , 1997, The Journal of clinical investigation.

[180]  K. Kuwano,et al.  P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. , 1996, American journal of respiratory and critical care medicine.

[181]  Kozo Kaibuchi,et al.  Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase) , 1996, Science.

[182]  B. Dautzenberg,et al.  Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. , 1996, Chest.

[183]  R. Hubbard,et al.  Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis , 1996, The Lancet.

[184]  J. Taipale,et al.  Association of the small latent transforming growth factor‐beta with an eight cysteine repeat of its binding protein LTBP‐1. , 1996, The EMBO journal.

[185]  E. Wang,et al.  Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. , 1995, Cancer research.

[186]  R. Leduc,et al.  Processing of Transforming Growth Factor 1 Precursor by Human Furin Convertase (*) , 1995, The Journal of Biological Chemistry.

[187]  C. Gallagher,et al.  Oxygen improves maximal exercise performance in interstitial lung disease. , 1994, American journal of respiratory and critical care medicine.

[188]  M. Yamaguchi,et al.  Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. , 1994, American journal of respiratory and critical care medicine.

[189]  K. Flanders,et al.  Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. , 1991, American journal of respiratory cell and molecular biology.

[190]  I. D. Johnston,et al.  What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. , 1990, BMJ.

[191]  R. Crystal,et al.  Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. , 1989, The American review of respiratory disease.

[192]  R. Crystal,et al.  Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. , 1987, The Journal of clinical investigation.

[193]  D. Lawrence,et al.  Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions , 1985 .

[194]  D. Lawrence,et al.  Normal embryo fibroblasts release transforming growth factors in a latent form , 1984, Journal of cellular physiology.

[195]  D. H. Matulionis.  Chronic cigarette smoke inhalation and aging in mice: 1. Morphologic and functional lung abnormalities. , 1984, Experimental lung research.

[196]  R. Crystal,et al.  Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. , 1983, The Journal of clinical investigation.